Delivery Order SPE2DB22D1106-SPE2DB24FFDV3
Award Date
7/24/24
Potential Completion Date
7/25/24
Potential Value
$40K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Olmesartan-HCTZ 40-12.5 mg tablets in 90-count packages to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $24,940.04. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 30, 2024. This award is part of a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $4,530.45 and is for the delivery of Olmesartan-HCTZ 40-12.5 mg tablets in 30-count packages. The contract has an ultimate completion date of November 21, 2023 and was awarded on November 20, 2023. The contract is not designated as a set-aside....
This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,659.68, is for the delivery of Olmesartan-HCTZ 40-12.5 mg tablets in 30-count packages. This award is not designated as a set-aside contract. The IDC held by AmerisourceBergen with the DLA Troop Support Medical is valued at $999,999,999 and runs through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,344.48 to AmerisourceBergen Drug Corporation, a subsidiary of parent company Cencora, Inc., to supply 4,563,956,598 units of the pharmaceutical product Olmesartan Medoxomil 40 mg tablets in 30-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corporation, valued at up to $999,999,999.00 through December 31, 2025,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,562,868,660 units of Olmesartan-HCTZ 40-25 mg tablets in 90-count bottles, with a firm fixed price ceiling of $26,326.05 and a completion date of November 21, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The order is for Olmesartan-HCTZ 40-12.5 mg tablets, a generic medication, and has a potential value of $14,670.10. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,448,722 units of Olmesartan Medoxomil 40 mg tablets. The contract has a completion date of January 26, 2024 and a potential value of $14,737.63. This delivery order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $7,210.58 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit organization, for the supply of Olmesartan Medoxomil 40 mg tablets. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp that has a potential value of $999,999,999.00 and runs through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
This is a $1,028.77 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Olmesartan-HCTZ 40-12.5 mg tablets. The contract has an ultimate completion date of July 31, 2024 and is a firm fixed-price contract. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for delivering a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, provides for the delivery of Olmesartan-HCTZ 40-25 mg tablets to the U.S. government. The $1,728.94 firm-fixed price Delivery Order contract, placed under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, supports the agency's mission to provide logistics, acquisition, and technical services to...